The Idaho State Board of Pharmacy has developed template protocols for pharmacists to consider when implementing services that include prescribing. Rule Docket 27-0104-1701, Rules Governing Pharmacist Prescriptive Authority, detailed the requirements related to “patient assessment protocols” required for each drug or drug category a pharmacist intends to prescribe. Of note, the state does not impose a […]
Study Shows Point-of-Care Testing Increases Patient Access to Care
A new study shows that collaborative physician-community pharmacy programs featuring point-of-care testing have the potential to improve patient care and population health. The study, published in the Research in Social and Administrative Pharmacy journal and funded by the NACDS Foundation, looked at flu and strep throat testing done through collaborative practice agreements. Read More Related: Collaborative […]
MEDISCA Announces First-Ever World Congress of Compounding
MEDISCA, the industry leader in providing high quality compounding solutions and services to pharmacists worldwide, announced today that it will host the first-ever World Congress of Compounding on October 27-28, 2018 in Las Vegas, NV. The conference is sponsored by MEDISCA and its global partners, MEDISCA Network and LP3 Network, and will feature renowned speakers from […]
Survey Suggests Most Consumers Keep Unused Opioids for Future Use
A recent survey commissioned by Allied Against Opioid Abuse (AAOA) reports that 89% of patients who keep their unused prescription opioids save them for future use. This statistic highlights the need to educate the public on the safe use and disposal of prescription opioids to ensure they do not end up in the wrong hands. […]
Pharmacist Prescribing Legislation Moves Forward in Minnesota
Pharmacist prescribing legislation in Minnesota is moving forward. HF 2962 gives pharmacists the authority to prescribe naloxone, smoking cessation medications, and travel medications. While HF 2962 has made it through all stops in the Minnesota House and is now moving through the finance legislative process, the companion Senate bill, SF 3015 is experiencing troubles, but […]
New Study Reports Non-Optimized Medication Therapy Costs $528.4 Billion Annually
New research indicates that illness and death resulting from non-optimized medication therapy cost $528.4 billion, or 16% of total health care spending in the U.S., in 2016. Researchers at Skaggs School of Pharmacy at the University of California San Diego studied not only nonadherence (not taking a medication correctly, or at all), but also non-optimized […]